Israel Englander’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,400
Closed -$1.62M 6461
2025
Q3
$1.62M Sell
14,400
-12,700
-47% -$1.49M ﹤0.01% 4238
2025
Q2
$3.63M Sell
27,100
-7,700
-22% -$845K ﹤0.01% 3312
2025
Q1
$2.34M Buy
34,800
+26,900
+341% +$1.85M ﹤0.01% 3636
2024
Q4
$493K Buy
7,900
+1,000
+14% +$93.1K ﹤0.01% 4764
2024
Q3
$1.08M Hold
6,900
﹤0.01% 4206
2024
Q2
$1.04M Sell
6,900
-103,500
-94% -$12.4M ﹤0.01% 4087
2024
Q1
$8.16M Buy
+110,400
New +$9.1M ﹤0.01% 2385
2023
Q4
Sell
-61,200
Closed -$3.35M 6536
2023
Q3
$3.35M Buy
+61,200
New +$4.41M ﹤0.01% 3095

Other funds holding TMDX

Israel Englander's TMDX Position: Q2 2026 in Review

Israel Englander reduced its Transmedics (TMDX) stake by 19% in Q2 2026, selling an estimated $4.89M and leaving 248,312 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #1802.

Israel Englander first reported a position in TMDX in Q2 2019 and has held it in 19 quarters since. The position peaked at $30.4M in Q1 2026. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Israel Englander held 248,312 shares of Transmedics worth $16.5M as of Q2 2026.
  • Israel Englander sold 57,768 Transmedics shares in Q2 2026, an estimated $4.89M.
  • Transmedics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1802 holding.
  • Israel Englander first reported a position in Transmedics in Q2 2019 and has held it in 19 quarters since.
  • Israel Englander's Transmedics position peaked at $30.4M in Q1 2026.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.